2019 Coronavirus Disease (COVID-19) Outbreak: A Review Article


2019 Coronavirus Disease (COVID-19) Outbreak: A Review Article


Melaku Tafese Awulachew*

Kulumsa Agricultural research center


In December 2019, an outbreak of severe acute respiratory syndrome coronavirus 2 infections occurred in Wuhan, Hubei Province, China and spread across China and beyond. On February 12, 2020, WHO officially named the disease caused by the novel coronavirus as Coronavirus Disease 2019(COVID-19). The COVID-19 is a respiratory illness caused by a coronavirus and pandemic is now a major global health threat. Coronaviruses (CoV) belong to the genus Coronavirus with its high mutation rate in the Corona viridae. This review focuses to have a preliminary opinion about the disease, the ways of treatment, and prevention in this early stage of COVID-19 outbreak.


Keywords: Global emerging disease outbreak, Clinical Symptom Spectrum, Diagnosis of COVID-19 Infection, Treatment and Protection


Free Full-text PDF


How to cite this article:
Melaku Tafese Awulachew. 2019 Coronavirus Disease (COVID-19) Outbreak: A Review Article.International Journal of Virology and Diseases, 2020, 3:12


References
1. Phelan AL, Katz R, Gostin LO. The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance. JAMA. 2020.
2. Wu Y, Ho W, Huang Y, et al. SARS-CoV-2 is an appropriate name for the new coronavirus. Lancet. 2020.
3. Bootsma MCJ, Ferguson NM. The effect of public health measures on the 1918 influenza pandemic in U.S. cities. Proc Natl Acad Sci U S A 2007;104(18):7588–93.
4. Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. Comment How will countrybased mitigation measures influence the course of the COVID-19 epidemic ? 2020;2019(20):1– 4.
5. The Coalition for Epidemic Preparedness Innovations. CEPI welcomes UK Government’s funding and highlights need for $2 billion to develop a vaccine against COVID-19 [Internet]. 2020;Available from: https://cepi.net/news_cepi/2-billion-required-to-develop-a-vaccineagainst-the-covid-19-virus/
6. World Health Organisation. Pandemic influenza A (H1N1) 2009 virus vaccine – conclusions and recommendations from the october 2009 meeting of the immunization Strategic Advisory Group of experts. Wkly Epidemiol Rec 2009;84(49):509–16.
7. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv preprint first posted online Feb. 9, 2020. doi: http://dx.doi.org/10.1101/2020.02.06.20020974. Accessed February 13, 2020. 27. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Feb 3. doi: 10.1038/s41586-020-2012-7. [Epub ahead of print]
8. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020 Feb 7. doi: 10.1001/jama.2020.1585. [Epub ahead of print]
9. Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 Jan 24. pii: S0140-6736(20)30154-9. doi: 10.1016/S0140-6736(20)30154-9. [Epub ahead of print]
10. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Jan 30. pii: S0140-6736(20)30211-7. doi: 10.1016/S0140-6736(20)30211-7. [Epub ahead of print]
11. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020 Jan 24. pii: S0140-6736(20)30183-5. doi: 10.1016/S0140-6736(20)30183-5. [Epub ahead of print]
12. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus(2019-nCoV) infection is suspected. 2019. At https://www.who.int/csr/disease/coronavirus_infections/InterimGuidance_ClinicalManage ment_NovelCoronavirus_11Feb13u.pdf?ua=1&ua=1. Accessed February 11, 2020.
13. General Office of National Health Committee. Office of State Administration of Traditional Chinese Medicine. Notice on the issuance of a program for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia (trial sixth edition) (2020-02-19)
14. In Press [EB/OL]. http://yzs.satcm.gov.cn/zhengcewenjian/2020-02-19/13221.html]
15. World Health Organization. WHO guidelines for the global surveillance of severe acute respiratory syndrome(SARS).2004.at https://www.who.int/csr/resources/publications/WHO_CDS_CSR_ARO_2004_1.pdf?ua= 1. Published January, 2004. Updated October, 2004.
16. World Health Organization. Middle East respiratory syndrome case definition for reporting to WHO. 2017. https://www.who.int/csr/disease/coronavirus_infections/mers-interim– case-definition.pdf?ua=1.
17. Azhar EI, El-Kafrawy SA, Farraj SA, et al. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med 2014; 370(26): 2499-505.
18. General Office of National Health Committee. Office of state administration of traditional Chinese medicine. Notice on the issuance of a programme for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia (trial fifth edition) (2020-02-26) [EB/OL]. http://bgs.satcm.gov.cn/zhengcewenjian/2020-02-06/12847.html]
19. World Health Organization. Coronavirus Disease 2019(COVID-19): situation report—28.2020.https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200217sitrep-28-covid-19.pdf?sfvrsn=a19cf2ad_2. Published February 18, 2020. Accessed February 20, 2020
20. World Health Organization. Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts [EB/OL]. https://www.who.int/publications-detail/home-care-for-patients-with-suspected-novelcoronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-ofcontacts. Published January 20, 2020. Accessed February 11, 2020
21. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; published online Jan 24. HYPERLINK “https://doi. org/10.1016/S01406736(20)301835” https://doi.org/10.1016/ S0140–6736(20)30183–5.
22. Hui D.S.; Azhar E.I:;Madani T.A.; Ntoumi F.; Kock R.; Dar O.; Ippolito G.; Mchugh T. D.;Memish Z.;Drosten C.;Zumla A.; Petersen E.; The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health -The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis, 2020 (91) ,264266
23. Chen N., Zhou M.; Dong X.; Qu J.;Gong F.; Han Y.; Qiu Y.; Wang J.;Liu Y.;Wei Y.; Xia J.;Yu T.; Zhang X.; Zhang L.; Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020, publish onlined Jan 29, https://doi.org/10.1016/ S01406736(20)30211-7
24. Arabi, Y. M., Alothman, A., Balkhy et. al. Treatment of Middle East respiratory syndrome with a combination of lopinavirritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial. Trials 2016; 19(1); 81.
25. WHO. Emergencies preparedness, response. Pneumonia of unknown origin – China. Disease outbreak news. Available online: https:// HYPERLINK “http://www.who.int/csr/don/12january-2020-novel-coronavirus-china/en/” www.who.int/ csr/don/12-january-2020-novel-coronavirus-china/en/ ( accessed on 05 February 2020)
26. Warren, T. K. et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature 531, 381–385 (2016)
27. Jordan, P. C. et al. Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase. PLoS Pathog. 14, e1006889 (2018).
28. Cockrell, A. S. et al. A mouse model for MERS coronavirus-induced acute respiratory distress syndrome. Nat. Microbiol 2, 16226 (2016)
29. Brown, A. J. et al. Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase. Antivir. Res. 2019; 169: 104541
30. 2019 Novel Coronavirus.Prevention and Treatment. Available online: https://www.cdc.gov/coronavirus/2019-ncov/about/ prevention-treatment.html (accessed on 05 February 2020)
31. Woo PC, Huang Y, Lau SK, Yuen KY. Coronavirus genomics and bioinformatics analysis. Viruses 2010;2:1804-20.